Comment on

• Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group.

  Woods KL, Ketley D, Lowy A, Agusti A, Hagn C, Kala R, Karatzas NB, Leizorowicz A, Reikvam A, Schilling J, Seabra-Gomes R, Vasiliauskas D, Wilhelmsen L. Woods KL, et al. Eur Heart J. 1998 Jan;19(1):74-9. doi: 10.1053/euhj.1997.0560. Eur Heart J. 1998. PMID: 9503178